Prospective, Open-Label Study of Pharmacokinetics of Ertapenem in the Muscle Using Microdialysis in Mechanically Ventilated Intensive Care Unit Patients, Treated or Not by Norepinephrine

Trial Profile

Prospective, Open-Label Study of Pharmacokinetics of Ertapenem in the Muscle Using Microdialysis in Mechanically Ventilated Intensive Care Unit Patients, Treated or Not by Norepinephrine

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 24 Feb 2014

At a glance

  • Drugs Ertapenem (Primary)
  • Indications Bacterial infections; Intra-abdominal infections; Pneumonia
  • Focus Pharmacokinetics
  • Most Recent Events

    • 09 Mar 2010 Planned end date (Apr 2009) added as reported by ClinicalTrials.gov.
    • 09 Mar 2010 Planned patient number (40) added as reported by ClinicalTrials.gov.
    • 31 Jul 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top